Guggenheim Capital LLC lessened its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 47.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,922 shares of the technology company's stock after selling 8,038 shares during the period. Guggenheim Capital LLC's holdings in Amdocs were worth $760,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of DOX. Pzena Investment Management LLC lifted its stake in shares of Amdocs by 4.3% in the fourth quarter. Pzena Investment Management LLC now owns 6,634,549 shares of the technology company's stock worth $564,866,000 after buying an additional 270,810 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Amdocs by 2.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company's stock valued at $274,681,000 after purchasing an additional 87,801 shares in the last quarter. Vanguard Group Inc. increased its holdings in Amdocs by 16.1% in the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after buying an additional 426,035 shares in the last quarter. Wellington Management Group LLP raised its position in Amdocs by 25.4% in the 4th quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after buying an additional 543,490 shares during the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in Amdocs by 7.4% in the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock worth $154,587,000 after purchasing an additional 125,654 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Price Performance
NASDAQ DOX traded up $1.00 during mid-day trading on Tuesday, hitting $87.78. The stock had a trading volume of 60,689 shares, compared to its average volume of 703,812. The firm's 50 day moving average is $87.01 and its 200 day moving average is $87.00. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 1.47 and a beta of 0.59. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $93.34.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Equities research analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.
Amdocs Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Monday, March 31st were paid a dividend of $0.527 per share. The ex-dividend date was Monday, March 31st. This is a boost from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.40%. Amdocs's dividend payout ratio is 48.72%.
Analyst Ratings Changes
Separately, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Amdocs currently has a consensus rating of "Moderate Buy" and an average price target of $101.20.
Get Our Latest Stock Analysis on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.